Keywords: ربامایپید; Contact lens; Dry eye syndrome; Mucins; Rebamipide; Tears;
مقالات ISI ربامایپید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ربامایپید; Acetyl salicylic acid; Small intestine; Mucus; Dietary emulsifier; Polysorbate 80; Rebamipide;
Keywords: ربامایپید; Barrier function; Intestine; Radiotherapy; Rebamipide;
Keywords: ربامایپید; Nanoparticle; Rebamipide; Particle size; Ophthalmic dispersion; Cornea; Abs; absorbance; BAC; benzalkonium chloride; CA; commercially available; HCE-T; human corneal epithelial cell line; HPβCD; 2-hydroxypropyl-β-cyclodextrin; MC; methylcellulose; OLETF
Keywords: ربامایپید; Ocular surface; Transmembrane mucins; Rebamipide; Stratified epithelium; Notch signaling;
Keywords: ربامایپید; tear secretion; ocular surface system; main lacrimal gland; accessory lacrimal gland; corneal epithelium; conjunctival epithelium; rebamipide; diquafosol
Keywords: ربامایپید; Rebamipide; HSC-2 tumor-bearing nude mice; Radiotherapy; Chemotherapy; Reactive oxygen species
Keywords: ربامایپید; urinary bladder; overactive; inflammation; cystitis; rebamipide; cyclophosphamideCYP, cyclophosphamide; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ICI, intercontraction interval; IL, interleukin; MPO, myeloperoxidase; TNF, tumor necrosis factor
Keywords: ربامایپید; NSAIDs; Rebamipide; Pharmacokinetics; HPLC; Celecoxib; Diclofenac
Therapeutic efficacy of rebamipide-loaded PLGA nanoparticles coated with chitosan in a mouse model for oral mucositis induced by cancer chemotherapy
Keywords: ربامایپید; Rebamipide; Oral mucositis; Nanoparticle; Poly(dl-lactide-co-glycolide); PLGA; Chitosan; Therapeutic efficacy; Mucin: mouse; Cancer chemotherapy;
Rebamipide suppresses 5-fluorouracil-induced cell death via the activation of Akt/mTOR pathway and regulates the expression of Bcl-2 family proteins
Keywords: ربامایپید; Rebamipide; Oral mucositis; 5-FU; Akt; mTOR;
Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis
Keywords: ربامایپید; Rebamipide; Oral mucositis; Radiation therapy; Chemotherapy; Oral cancer; Head & neck cancer;
Rebamipide reduces amyloid-β 1-42 (Aβ42) production and ameliorates Aβ43-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells
Keywords: ربامایپید; Aβ; amyloid-beta; AD; Alzheimer's disease; ADAM; a disintegrin and metalloproteinase; APP; amyloid precursor protein; ASPD; amylospheroids; BCA; bicinchoninic acid; BACE1; β-site APP-cleaving enzyme-1; BDNF; brain-derived neurotrophic factor; BSA; bov
Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells
Keywords: ربامایپید; Rebamipide; Helicobacter pylori CagA; Gastric cancer-initiating cells; β-Catenin; microRNA-320a/-4496; Rebamipide (PubChem CID: 5042); 5-Fluorouracil (PubChem CID: 3385); Paclitaxel (PubChem CID: 36314); Irinotecan hydrochloride (PubChem CID: 74990);
Preventive effect of rebamipide on N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats
Keywords: ربامایپید; N-methyl-N′-nitro-N-nitrosoguanidine; Rebamipide; Gastric cancer; Rat; ChemopreventionGC, gastric cancer; HP, Helicobacter pylori; MNNG, N-methyl-N′-nitro-N-nitrosoguanidine; CgA, chromogranin A; HE, hematoxylin and eosin; AB/PAS, Alcian-blue/periodic aci
Enhanced bioavailability of rebamipide nanocrystal tablets: Formulation and in vitro/in vivo evaluation
Keywords: ربامایپید; Rebamipide; Nanocrystal; Dissolution; Pharmacokinetics
The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: Comparison study with rebamipide
Keywords: ربامایپید; Polaprezinc; Zinc; Carnosine; Rebamipide; Gastric ulcer
Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats
Keywords: ربامایپید; NSAIDs; Rebamipide; Kidney; Prostaglandin; Cyclooxygenase; Electrolyte
Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis
Keywords: ربامایپید; Celecoxib; Rebamipide; Ulcer; Apoptosis; Voltage-dependent L-type Ca2+ channel
Oxidative stress induces gastric epithelial permeability through claudin-3
Keywords: ربامایپید; Tight junction; Rebamipide; Permeability; Claudin-3; siRNA
Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behcet's disease mouse model
Keywords: ربامایپید; Rebamipide; Behcet's disease; Herpes simplex virus; Mouse model; NADPH oxidase
Rebamipide, anti-gastric ulcer drug, up-regulates the induction of iNOS in proinflammatory cytokine-stimulated hepatocytes
Keywords: ربامایپید; Rebamipide; Interleukin-1β; Nitric oxide; Inducible nitric oxide synthase; Nuclear factor-κB; Type I interleukin-1 receptor; mRNA stabilization; Antisense-transcript; Hepatocyte
The inhibitory effects of rebamipide on cigarette smoke-induced airway mucin production
Keywords: ربامایپید; Smoking; Epidermal growth factor receptor; TNFα; Mucin; Rebamipide
Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B
Keywords: ربامایپید; Gastric cancer; Apoptosis; Survivin; Aurora-B; Rebamipide; Proteasome inhibitor;